(Q53435821)
Statements
Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies. (English)
Anders Osterborg
Y Brandberg
V Molostova
G Iosava
K Abdulkadyrov
M Hedenus
D Messinger
Epoetin Beta Hematology Study Group
1 May 2002
20
10
2486-2494